CPC A61K 31/352 (2013.01) [A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 31/05 (2013.01); A61P 29/00 (2018.01)] | 14 Claims |
1. A method of treating inflammation or edema in a patient in need thereof comprising:
administering a therapeutically effective amount of a gel composition to the patient in need thereof, the composition comprising
at least one cannabinoid present in the composition at a concentration of between about 1% (w/w) to about 15% (w/w);
a combination of permeation enhancers each present in the composition at a concentration of between about 9% (w/w) to about 43% (w/w) wherein the combination of permeation enhancers comprises lactic acid (LA), polyethylene glycol-400 (PEG-400), N-methyl-2 pyrrolidone (NMP), and dimethyl sulfoxide (DMSO); and
at least one hydrophilic polymer present in the composition at a concentration of between about 1% (w/w) to about 5% (w/w) wherein the at least one hydrophilic polymer is selected from the group consisting of hydroxyethyl cellulose (HEC), methylcellulose (MC), ethylcellulose (EC), hydroxypropyl cellulose (HPC), hydroxyethyl methylcellulose (HEMC), hydroxypropyl methylcellulose (HPMC), sodium carboxymethylcellulose (NaCMC), and combinations thereof;
wherein the administration of the composition treats the inflammation or edema of the patient.
|